More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

Halozyme Therapeutics HALO is scheduled to report fourth-quarter and full-year 2024 results on Feb. 18, after market close.

Rupert’s shocking decision was the climax of a succession battle that had pitted James and Lachlan, born just 15 months apart ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Morgan Stanley has assumed coverage of Halozyme Therapeutics (NASDAQ:HALO) with an overweight rating, citing its diversified revenue stream. The investment bank said the stock "was an alternative for ...

Get the full experience! Unlock access to all videos with the Unlimited Trains.com Membership.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Researchers found that high fructose intake, especially from processed foods, is linked to metabolic dysfunction-associated ...

Research has uncovered key differences in gene expression linked to inflammation, metabolism and cardioprotection. These findings could help inform the development of targeted therapies for ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

CBL-514, the world's first investigational drug for large-area localized fat reduction, has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.54.2% ...